• LAST PRICE
    34.2800
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    20.0000/ 10
  • Ask / Lots
    50.0000/ 5
  • Open / Previous Close
    0.0000 / 34.2800
  • Day Range
    ---
  • 52 Week Range
    Low 25.6000
    High 77.6000
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 33.35
TimeVolumeIRON
09:32 ET111331.82
09:34 ET20031.8
09:36 ET20031.6
09:43 ET5057732
09:50 ET20032.96
10:01 ET82633.59
10:08 ET140033.12
10:10 ET40033.11
10:12 ET40033.22
10:15 ET8760633.07
10:17 ET10032.92
10:19 ET20032.81
10:21 ET20032.8
10:26 ET10032.54
10:28 ET35332.4552
10:30 ET10032.42
10:33 ET418832.87
10:35 ET10032.88
10:37 ET10032.99
10:42 ET10033.13
10:48 ET10033.13
10:53 ET50033.37
10:55 ET20033.47
10:57 ET10033.49
11:00 ET10033.49
11:11 ET30033.63
11:18 ET163433.57
11:22 ET58233.685
11:27 ET350633.48
11:29 ET10033.495
11:31 ET20033.6
11:33 ET20033.69
11:36 ET20033.65
11:42 ET85033.86
11:44 ET32333.76
11:45 ET20033.86
11:47 ET10033.91
11:49 ET12633.9
11:54 ET20033.73
11:56 ET140033.745
11:58 ET170434.05
12:00 ET55034.07
12:09 ET20034.25
12:12 ET40034.25
12:18 ET182734.03
12:20 ET100634.09
12:21 ET10034.07
12:23 ET10034.15
12:25 ET40034.17
12:27 ET10034.27
12:30 ET10034.2885
12:32 ET10034.23
12:34 ET10034.26
12:36 ET20034.26
12:38 ET50034.3
12:39 ET10034.35
12:41 ET10034.38
12:45 ET50034.325
12:48 ET5189934.275
12:50 ET40034.075
12:52 ET10033.94
12:54 ET40034.035
12:56 ET50034.11
12:57 ET30034.19
12:59 ET71934.23
01:03 ET20034.23
01:06 ET40034.28
01:08 ET10034.2676
01:10 ET15234.28
01:12 ET10034.39
01:14 ET10034.38
01:15 ET10034.37
01:17 ET20034.33
01:19 ET65434.24
01:21 ET34234.22
01:26 ET20034.215
01:32 ET23634.2
01:33 ET70233.955
01:39 ET20033.87
01:42 ET10033.96
01:44 ET10033.98
01:46 ET22533.8
01:50 ET30033.84
01:51 ET40033.98
01:53 ET20033.945
02:00 ET10033.94
02:04 ET41033.71
02:08 ET10033.61
02:11 ET30033.685
02:13 ET10033.75
02:15 ET70333.75
02:18 ET300034.02
02:20 ET10120934.06
02:24 ET220034.33
02:26 ET50534.25
02:27 ET28834.2
02:29 ET10034.3
02:31 ET10034.32
02:36 ET330634.23
02:38 ET30034.055
02:40 ET110034.05
02:42 ET20034.03
02:44 ET20033.92
02:47 ET10033.95
02:49 ET20033.98
02:51 ET40034
02:54 ET10034.05
02:56 ET40033.945
02:58 ET20033.885
03:00 ET20033.94
03:02 ET40033.945
03:03 ET87533.81
03:05 ET110033.95
03:07 ET40033.99
03:09 ET20034.13
03:12 ET10034.13
03:14 ET10033.99
03:16 ET20034.13
03:20 ET90234.15
03:21 ET30034.22
03:23 ET10034.3
03:27 ET30034.31
03:30 ET103134.12
03:32 ET60034.16
03:34 ET50934.19
03:36 ET70034.1
03:38 ET60034.23
03:39 ET67634.34
03:41 ET260934.35
03:43 ET60034.36
03:45 ET283734.28
03:48 ET150034.26
03:50 ET82934.24
03:52 ET866034.79
03:54 ET365834.75
03:56 ET329234.7
03:57 ET858734.415
03:59 ET1101234.28
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesIRON
Disc Medicine Inc
847.5M
-10.2x
---
United StatesSRRK
Scholar Rock Holding Corp
851.0M
-5.1x
---
United StatesHUMA
Humacyte Inc
851.5M
-7.1x
---
United StatesPRME
Prime Medicine Inc
831.2M
-3.2x
---
United StatesSPRY
ARS Pharmaceuticals Inc
870.1M
-17.3x
---
United StatesCRGX
CARGO Therapeutics Inc
821.4M
-7.2x
---
As of 2024-05-28

Company Information

Disc Medicine, Inc. is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. The Company's pipeline includes bitopertin for the treatment of erythropoietic porphyrias (Eps) including erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF), and anemia of chronic kidney disease (CKD), and DISC-3405 (formerly MWTX-003) for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, its preclinical programs also include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Bitopertin is the lead product candidate in the Company's heme biosynthesis modulation portfolio. It is developing DISC-3405, a monoclonal antibody against Transmembrane Serine Protease 6 that it licensed from Mabwell Therapeutics, Inc.

Contact Information

Headquarters
321 Arsenal Street, Suite 101WATERTOWN, MA, United States 02472
Phone
617-674-9274
Fax
302-655-5049

Executives

Executive Chairman of the Board
Donald Nicholson
President, Chief Executive Officer, Director
John Quisel
Chief Financial Officer, Treasurer
Jean Franchi
Chief Operating Officer
Jonathan Yu
General Counsel
Rahul Khara

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$847.5M
Revenue (TTM)
$0.00
Shares Outstanding
24.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.52
EPS
$-3.37
Book Value
$14.17
P/E Ratio
-10.2x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.